LONGBOARD PHARMACEUTICALS IN (LBPH)
US54300N1037 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -54.42M | -43.95M | -27.80M | -14.40M | |||
| Depreciation Amortization | 5.00K | 10.00K | 0.00 | N/A | |||
| Change In Working Capital | 1.27M | 3.12M | 970.00K | 2.45M | |||
| Other non cash items | 2.28M | 2.76M | 2.12M | 8.51M | |||
| OPERATING CASH FLOW | -50.87M | -38.06M | -24.71M | -3.44M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | N/A | 0.00 | -20.00K | N/A | |||
| Other Investing Activity | 24.23M | -17.06M | -40.70M | N/A | |||
| INVESTING CASH FLOW | 24.23M | -17.06M | -40.72M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Stock Issued/Repurchased | 32.28M | 0.00 | 84.77M | 59.20M | |||
| Other Financing Activity | -2.09M | -440.00K | -8.32M | -440.00K | |||
| FINANCING CASH FLOW | 30.19M | -440.00K | 76.45M | 58.76M | |||
| CHANGE IN CASH | 3.56M | -55.56M | 11.02M | 55.32M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -50.87M | -38.06M | -24.71M | -3.44M | |||
| Capital Expenditure | N/A | 0.00 | -20.00K | N/A | |||
| FREE CASH FLOW | -50.87M | -38.06M | -24.73M | -3.44M | |||
All data in USD